Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study

Jul-11

AUTHORS : Prof Michael Kirby, University of Hertfordshire, Hatfield AL10 9AB, UK – Email: kirbym@globalnet.co.uk – Profile: https://researchprofiles.herts.ac.uk/portal/en/persons/michael-kirby(ed3051f0-e4f7-484d-bd77-e3c40bfd8219).html AND http://www.pctag.uk/2016/08/dr-mike-kirby-frcp/

JOURNAL : International Journal of Clinical Practice

REFERENCE: 65(7):797-806

DOI : 10.1111/j.1742-1241.2011.02693.x

Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Increased risk of fracture among patients with iron overload: a population-based matched cohort study